Global brokerage firm Nomura has initiated coverage on the newly listed Anthem Biosciences with a ‘Buy’ rating and a target price of Rs 740 for December 2026, implying an upside of 18% from current levels.The initiation comes despite the stock falling 22.4% over the past three months since listing in July 2025. Nomura believes the […]
Shares of Netflix fell more than 10% on Wednesday as the streaming giant’s outlook for the coming quarter left investors stunned despite a strong slate of shows including the final season of “Stranger Things.” Investors have become accustomed to the company’s routine outperformance, which has propelled its shares to gains of more than 360% over […]